Real-time enrollment status for this prurigo nodularis (pn) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:52 AM UTC
| NCT Number | NCT07236099 |
| Recruiting Status | Recruiting |
| Condition | Prurigo Nodularis (PN) |
| Phase | PHASE2 |
| Target Enrollment | 135 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Beijing InnoCare Pharma Tech Co., Ltd. |
| Last Updated on CT.gov | April 9, 2026 (Apr 9, 2026) |
As of July 18, 2026: Clinical trial NCT07236099 is currently recruiting participants. This phase2 study for prurigo nodularis (pn) is actively seeking new participants at 1 location across the United States. The study is sponsored by Beijing InnoCare Pharma Tech Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07236099 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07236099 was last updated Apr 9, 2026 (April 9, 2026). HelloStudys verifies this status automatically.